Blood compatibility device of blood pump

By using the patient console and blood monitoring module in the intravascular blood pump system, blood coagulation is monitored and controlled in real time and potential risks are predicted, and the problem of long time and poor accuracy of blood coagulation monitoring and control in the prior art is solved, and the problem of poor blood coagulation monitoring and control in the prior art is achieved. Safer blood treatment.

CN119095644APending Publication Date: 2024-12-06ABIOMED INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380039078.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-18
Filing Date
2023-03-17
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Monitoring and controlling blood clotting is challenging when using an intravascular blood pump, and existing methods may take too long or not accurate enough, resulting in poor correlation of anticoagulation regimens and potentially leading to the risk of bleeding events or thrombosis.

Method used

Provides a system and method that includes a patient console and a blood monitoring module to receive information about blood samples through a blood monitoring sensor, calculate blood parameters such as prothrombin time and activated coagulation time, and display these parameters on the display screen, Based on these parameters, blood pumps are controlled to regulate the use of anticoagulants, and processors and machine learning algorithms are used to predict potential bleeding events or risk of heart failure.

Benefits of technology

Fast and accurate blood coagulation monitoring and control is achieved, reducing the risk of bleeding events and thrombosis, improving the accuracy of anticoagulation regimens, and enabling timely adjustment of blood pump operation to prevent complications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095644A_ABST
    Figure CN119095644A_ABST
Patent Text Reader

Abstract

Systems and methods are disclosed relating to a pump control module configured to control an intravascular blood pump and display information about the intravascular blood pump, and a blood monitoring module, the blood monitoring module is configured to derive a value of a blood parameter from received information about a blood sample, such as information received from a blood monitoring sensor, and to display the value of the blood parameter on the first display screen and / or the second display screen. The system and method may also include predicting other parameters based on, for example, information received from the blood sample. The prediction may include, for example, a prediction of a heart failure or bleeding event.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to U.S. Provisional Patent Application No. 63 / 321,437, filed on March 18, 2022, the contents of which are incorporated herein by reference in their entirety. Technical Field

[0003] Embodiments disclosed herein relate to medical devices, such as intravascular blood pumps, and devices and methods for monitoring and / or controlling blood coagulation. Background Art

[0004] When using a medical device such as an intravascular blood pump, it is useful to attempt to monitor and control blood coagulation. For example, monitoring and controlling blood coagulation may be useful because when a medical device that contacts blood is introduced, human blood will naturally coagulate due to activation of the contact pathway. Typically, blood coagulation is controlled by providing a controlled dose of an anticoagulant. Too much anticoagulant may result in bleeding events, which may be an unacceptable outcome when using a blood pump, while too little anticoagulant may risk clotting and thrombosis, which may also be undesirable.

[0005] An intravascular blood pump can be surgically or percutaneously introduced into a patient's body and is used to transport blood from one location in the heart or circulatory system to another location in the heart or circulatory system. For example, when deployed in the left heart, the intravascular blood pump can pump blood from the left ventricle of the heart to the aorta. Similarly, when deployed in the right heart, the intravascular blood pump can pump blood from the inferior vena cava to the pulmonary artery. Examples of such blood pumps include the IMPELLA ® Series device (Abiomed, Danvers, Mass.). Summary of the invention

[0006] To provide useful rapid tests, new systems and techniques are disclosed.

[0007] A first aspect relates to a system that may include a patient console having a first housing with a first display screen, a pump control module at least partially disposed within the first housing, and a blood monitoring module. The pump control module may be configured to control an intravascular blood pump and display information about the blood pump on the display screen. The blood monitoring module may be configured to derive a value of a blood parameter based on information about a blood sample received from a blood monitoring sensor and display the value of the blood parameter on the first display screen and / or a second display screen.

[0008] In some embodiments, the system may include a processor. In some embodiments, the pump control module and the blood monitoring module are operably coupled to the processor. In some embodiments, the processor may include a plurality of processors, including a first processor and a second processor. In some embodiments, the first processor may be disposed in or on the pump control module, and the second processor may be disposed in or on the blood monitoring module. In some embodiments, the processor is disposed only within the first housing.

[0009] In some embodiments, the blood monitoring module may be within the first housing. In some embodiments, the system may include a blood monitoring console. The blood monitoring module may have a second housing. The second housing may have a second display screen. In some embodiments, the blood monitoring module may be disposed in the second housing. In some embodiments, the blood monitoring console may be coupled to a patient console. In some embodiments, the blood monitoring console may be removably coupled to the first housing. In some embodiments, the blood monitoring module may be at least partially disposed in the first housing.

[0010] In some embodiments, the system may include a first port configured to receive a blood sample. The blood sample can be received in various ways. In some embodiments, the first port can be configured to removably receive a box containing a blood sample. In some embodiments, the first port can be configured to be operably coupled to a catheter or tube. In some embodiments, the catheter or tube can be configured to, in addition to allowing blood to be transported therethrough, also include an electrical connection with a blood pump and / or an access delivery device (e.g., a delivery sheath). In some embodiments, the catheter or tube can be operably connected to the patient at a position different from the insertion point of the intravascular blood pump, wherein the catheter is configured to transfer the blood sample from the patient to the first port. In some embodiments, the catheter or tube can be operably connected to the intravascular blood pump, wherein the catheter is configured to transfer the blood sample from the patient to the first port.

[0011] In some embodiments, the blood monitoring sensor can be configured to sense a blood parameter of a blood sample received in the first port. In some embodiments, the first port can be disposed in a blood monitoring console coupled to a patient console, or disposed in the patient console.

[0012] In some embodiments, the system can include a second port configured to allow blood to exit the housing. In some embodiments, the second port can be connected to a waste stream.

[0013] In some embodiments, the blood monitoring sensor is located away from the blood monitoring module. In some embodiments, the blood monitoring sensor is disposed on an intravascular blood pump. In some embodiments, the blood monitoring sensor is disposed on a removable patch on the patient's skin.

[0014] In some embodiments, blood parameters may include or relate to blood coagulation. In some embodiments, blood parameters may include prothrombin time (PT), activated clotting time (ACT), clot proliferation rate, clot strength, clot decomposition rate, platelet mapping, functional fibrinogen and / or fibrin polymerization. In some embodiments, blood parameters may include international normalized ratio (INR).

[0015] A second aspect relates to a system that may include a pump control module configured to control an intravascular blood pump, and one or more processors. The one or more processors may be in operative communication with the pump control module. The one or more processors may be within a patient console and / or a blood monitoring console.

[0016] The one or more processors are configured with instructions that, when executed by the one or more processors, cause the system to perform specific tasks. Such tasks may include receiving information about a blood sample from a sensor, determining a value of a blood parameter based on the information about the blood sample, and displaying the value of the blood parameter on a first display screen and / or a second display screen.

[0017] In some embodiments, one or more processors may be configured with instructions that, when executed, cause the system to receive a blood sample. In some embodiments, the processor may include a plurality of processors, including a first processor and a second processor. In some embodiments, the first processor may be disposed in or on a pump control module, and the second processor may be disposed in or on a blood monitoring module. In some embodiments, the processor is disposed only within the first housing.

[0018] In some embodiments, the pump control module can be at least partially disposed in the first housing. In some embodiments, the blood monitoring module can be at least partially disposed in the first housing. In some embodiments, the blood monitoring module can be within the first housing. In some embodiments, the blood monitoring module can be disposed in a second housing having a second display screen. In some embodiments, the second housing can be coupled to the first housing. In some embodiments, the second housing can be removably coupled to the first housing.

[0019] In some embodiments, the one or more processors can be configured to cause the blood sample to be delivered to the blood monitoring console. In some embodiments, the blood sample can be retrieved by an intravascular blood pump. In some embodiments, the blood sample can be delivered to the housing via a catheter.

[0020] In some embodiments, one or more processors may be configured with instructions that, when executed, cause the system to adjust one or more valves to control the flow of a blood sample through the system.

[0021] In some embodiments, blood parameters may include or relate to blood coagulation. In some embodiments, blood parameters may include prothrombin time (PT), activated clotting time (ACT), clot proliferation rate, clot strength, clot decomposition rate, platelet mapping, functional fibrinogen and / or fibrin polymerization. In some embodiments, blood parameters may include international normalized ratio (INR).

[0022] A third aspect relates to a method. The method may include receiving information about a blood sample from a blood monitoring sensor, which may be disposed in a blood monitoring console. The method may include determining a value of a blood parameter based on the received blood sample information, wherein the blood parameter is blood coagulation or is related to blood coagulation. The method may include displaying the value of the blood parameter on a display screen of a patient console and / or a blood monitoring console. The method may include operating a blood pump via a module at least partially disposed in a patient console.

[0023] In some embodiments, the method may include controlling a blood pump based on the determined value of the blood parameter.

[0024] In some embodiments, the method may include predicting at least one other parameter using the value of a blood parameter, and may also include predicting at least one other parameter using the value of a sensor coupled to a blood pump. For example, in some embodiments, other parameters may include future (e.g., predictive) bleeding events and / or bleeding complications. In some embodiments, at least one other parameter is predicted using a trained machine learning algorithm. In some embodiments, the trained machine learning algorithm also uses the value from a thromboelastogram to predict at least one other parameter. In some embodiments, at least one other parameter may include a prediction of heart failure, such as a prediction of right heart failure. In some embodiments, the prediction of heart failure is performed when the blood pump is at least partially positioned within the left ventricle. In some embodiments, the at least one other parameter may include a prediction of a bleeding condition.

[0025] In some embodiments, the method may include determining an anticoagulation measure based on at least one other parameter of the prediction. In some embodiments, the method may include displaying the anticoagulation measure (e.g., on a first display screen or a second display screen). In some embodiments, the method may include automatically formulating the anticoagulation measure. In some embodiments, the anticoagulation measure may include determining or applying a dose of an anticoagulant (such as heparin or protamine).

[0026] In some embodiments, the method may include receiving a blood sample. In some embodiments, receiving a blood sample may include receiving the blood sample in a first port disposed on a patient console or a blood monitoring console. In some embodiments, the blood sample may be in a box or a vial. In some embodiments, the first port may be configured to be operably coupled to a catheter or a tube. In some embodiments, the catheter may be configured to transfer the blood sample from the patient to the first port. In some embodiments, the method may include obtaining a blood sample via an intravascular blood pump.

[0027] In some embodiments, blood parameters may include prothrombin time (PT), activated clotting time (ACT), clot proliferation rate, clot strength, clot disintegration rate, platelet mapping, functional fibrinogen and / or fibrin polymerization. In some embodiments, blood parameters may include international normalized ratio (INR).

[0028] A fourth aspect relates to a method. The method may include receiving a value of a blood parameter from a blood monitoring sensor configured as a monitoring patch disposed on a patient's body, displaying the value of the blood parameter on a display screen of a patient console, and operating an intravascular blood pump via a module at least partially disposed in the patient console.

[0029] In some embodiments, the method may include controlling a blood pump based on the value of the blood parameter.

[0030] In some embodiments, the method may include predicting at least one other parameter using the value of a blood parameter, and may also include predicting at least one other parameter using the value of a sensor coupled to a blood pump. For example, in some embodiments, other parameters may include future (e.g., predictive) bleeding events and / or bleeding complications. In some embodiments, at least one other parameter is predicted using a trained machine learning algorithm. In some embodiments, the trained machine learning algorithm also uses the value from a thromboelastogram to predict at least one other parameter. In some embodiments, at least one other parameter may include a prediction of heart failure, such as a prediction of right heart failure. In some embodiments, the prediction of heart failure is performed when the blood pump is at least partially positioned within the left ventricle. In some embodiments, the at least one other parameter may include a prediction of a bleeding condition.

[0031] In some embodiments, the method may include determining an anticoagulation measure based on the predicted at least one other parameter.

[0032] In some embodiments, the blood parameter may include or relate to blood coagulation. In some embodiments, the blood parameter may include prothrombin time (PT). In some embodiments, the blood parameter may include international normalized ratio (INR). BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 is a schematic diagram of an embodiment of a system.

[0034] Figure 2A and 2B is a diagram of a system in which a blood monitoring console is physically coupled to a patient console, wherein the blood monitoring console has a display (2A) or does not have a display (2B).

[0035] Figure 2C is an illustration of a system in which a blood monitoring console is integrated with a patient console.

[0036] Figure 2D and 2E is an illustration of a system connected to an intravascular heart pump introduced into a patient at a first insertion point, wherein a blood sample may be collected through the first insertion point (2D) or a second insertion point (2E).

[0037] Figure 2F is an illustration of a system for manually collecting a blood sample and transferring it to a console.

[0038] Figure 3 is an illustration of a system in which the blood monitoring sensor is located remotely from the console.

[0039] Figure 4 is an illustration of a system in which at least some blood monitoring consoles may be coupled to the patient rather than to a patient console.

[0040] Figure 5 is a flow chart of a method embodiment.

[0041] Figure 6 is a schematic diagram of another embodiment of the system. DETAILED DESCRIPTION

[0042] Embodiments of the present disclosure are described in detail with reference to the accompanying drawings, wherein the same reference numerals identify similar or identical elements. It should be understood that the disclosed embodiments are merely examples of the present disclosure, which may be embodied in various forms. Well-known functions or configurations are not described in detail to avoid obscuring the present disclosure with unnecessary details. Therefore, the specific structural and functional details disclosed herein should not be interpreted as restrictive, but only as the basis for the claims and as a representative basis for teaching those skilled in the art to teach in various ways.

[0043] When using a medical device such as an intravascular blood pump, it may be useful to attempt to monitor and control blood coagulation. For example, when a medical device that contacts blood is introduced, human blood will naturally coagulate due to activation of the contact pathway. In order to control blood coagulation, a controlled dose of an anticoagulant is typically provided to the patient. It is understood that too much anticoagulant may result in a bleeding event, which may be an unacceptable outcome when using a blood pump, while too little anticoagulant may present a risk of coagulation and thrombosis, which may also be undesirable.

[0044] Unfortunately, current methods for monitoring coagulation, including activated partial thrombotic clotting time (aPTT), anti-Xa assays, and thromboelastometry (TEG), may take too long, which may make them ineffective in the case of rapidly changing coagulation conditions in critically ill patients. In addition, these conventional techniques may be poorly correlated with bleeding events, resulting in anticoagulation regimens that are generally imprecise. In view of the foregoing, the inventors have recognized the benefits of new methods for measuring and managing the anticoagulation status of patients.

[0045] Turning now to the accompanying drawings, Figure 1 As shown, in some embodiments, a system 100 can be provided, which can include a patient console 110. The patient console can include a housing 120 (e.g., a first housing) having a display screen 130 (e.g., a first display screen). In some embodiments, the system 100 can also include a blood monitoring console 220. In such embodiments, the blood monitoring console can include a housing 280 (e.g., a second housing). In some embodiments, the display 230 (e.g., a second display) can be disposed within the second housing 280. In some embodiments, the patient console 110 and / or the blood monitoring console 220 can include one or more knobs, buttons, or controls 170, 270 with which a user can interact.

[0046] The system 100 can also include a pump control module 140, which can be at least partially disposed within the first housing 120. The pump control module can be configured to control an intravascular blood pump 150, as described herein.

[0047] Different types of blood pumps are known, such as axial flow blood pumps, centrifugal blood pumps or hybrid blood pumps, in which the blood flow is caused by both axial and radial forces. One such example of a blood pump is the Impella blood pump. ® series (for example, Impella2.5 ® , Impella CP ® , Impella 5.5 ® The intravascular blood pump can be inserted into the patient's blood vessels, for example, through the aorta, via a catheter.

[0048] Such a blood pump may involve the use of many medical devices, fluid lines, etc. These fluid lines may provide necessary fluids to the patient, may remove or recirculate fluids (e.g., blood) from the patient, or may provide fluids required by the medical device, such as cleaning fluids. For example, in some blood pumps, cleaning fluids may be configured to prevent blood from entering the pump mechanism and mitigate the effects of blood and / or biological deposit accumulation on the pump mechanism.

[0049] The pump control module may contain all the circuits and components required to control the intravascular blood pump and receive information from any sensors in or on the blood pump. For example, the module may include circuits to control the power to rotate the blood pump and to receive information from one or more pressure sensors. The pump control module may also be configured to display information about the blood pump on display screen 150.

[0050] In some embodiments, the system 100 may further include a blood monitoring module 200 configured to derive a value of a blood parameter based on information received from the blood monitoring sensor 210 about the blood sample 300. In some embodiments, the blood parameter includes or is related to blood coagulation (e.g., the blood parameter may be a value representing the degree or amount of blood coagulation, the concentration of a chemical or protein related to blood coagulation, etc.).

[0051] In some embodiments, the blood parameter may include prothrombin time (PT). As known in the art, PT generally relates to the time it takes for plasma to clot after adding a mixture comprising tissue factor and phospholipids (e.g., thromboplastin) to a patient's plasma sample.

[0052] Because the same plasma can provide different results based on the composition of thromboplastin, in some embodiments, the blood parameter may include an international normalized ratio (INR). As known in the art, INR generally relates to the ratio of the measured PT divided by the control PT value, wherein the control PT value is obtained using a reference thromboplastin reagent.

[0053] In some embodiments, blood parameters may also include activated clotting time (ACT), clot proliferation rate, clot strength, clot dissociation rate, platelet mapping, functional fibrinogen and / or fibrin polymerization.

[0054] In some embodiments, the blood monitoring module 200 may also be configured to display the value of the blood parameter on the first display screen 130 and / or the second display screen 230 .

[0055] In various embodiments and scenarios, there may be varying degrees of integration between the patient console and the blood monitoring console and / or blood monitoring module.

[0056] In some embodiments, the blood monitoring console 220 can be operably connected to the patient console 110, but physically separated from the patient console 110. In some embodiments, the blood monitoring console can be electrically coupled to the patient console. In some embodiments, the blood monitoring console can communicate wirelessly with the patient console.

[0057] like Figure 2A As shown, in some embodiments, the blood monitoring console 221 can be physically connected to the patient console 111. In some embodiments, the second housing 281 can be configured to be attached to the first housing 121. In some embodiments, the blood monitoring console 221 can be removably connected to the patient console 111. In some non-limiting examples, the side 191 of the first housing 121 includes a slot and a locking mechanism so that a portion of the second housing 281 can be removably slid into the slot until it is in the correct position (e.g., in a position to allow electrical contacts from each console to connect), and temporarily locked in place until the user presses a button or lever to release the locking mechanism. It should be understood that in other embodiments, other suitable fasteners can be used to connect the patient console and the monitoring console together.

[0058] In some embodiments, each console may include at least one processor. In some embodiments, the blood monitoring console 221 may include the blood monitoring module 201, but the blood monitoring console 221 may not have one or more processors 160, 260. That is, in some embodiments, the processor may be disposed only in the first housing.

[0059] like Figure 2A As shown, in some embodiments, both the patient console and the blood monitoring console may include a display. Figure 2B As shown, in other embodiments, the system 102 can be configured such that the first housing 122 for the patient console 112 has a display 130, but the second housing 282 for the blood monitoring console 222 does not include a display. In some embodiments, the second housing can also be devoid of buttons, knobs, or controls 270. In some embodiments, the blood monitoring console 222 can include a blood monitoring module 202, but the blood monitoring console 222 can be devoid of one or more processors 160, 260.

[0060] like Figure 2C As shown, in some embodiments, the system can be fully integrated. That is, in some embodiments, the system 103 can be configured such that the blood monitoring module 203 is at least partially within the first housing 123 defining the patient console 113.

[0061] refer to Figure 1In some embodiments, the system 100 may include a first port 240 configured to receive a blood sample 300. In some embodiments, the first port may be provided in a blood monitoring console 220 coupled to a patient console (see, e.g., Figure 2A and 2B ). In some embodiments, the first port 240 can be configured to removably receive a cartridge 310 (including, for example, a vial) containing a blood sample 300. Figure 2C In some embodiments, the first port 243 may be disposed in the patient console 113 .

[0062] refer to Figure 2D , in some embodiments, the first port 243 can be configured to be operably coupled to a catheter or tube 400. For example, in some embodiments, an intravascular heart pump 150 can be positioned in a heart 510 of a patient 500. For example, in some embodiments, a blood sample can be captured by the blood pump 150 and delivered to the patient console 113 through the catheter 400. That is, in some embodiments, the catheter or tube 400 can be operably coupled to the intravascular blood pump 150, wherein the catheter or tube 400 is configured to transfer the blood sample from the patient to the first port 243. In the illustrative example, the inlet port on the blood pump can draw blood from the patient and into the blood pump, which can then be used for delivery to the patient console 113.

[0063] In some embodiments, the catheter or tube 400 may be configured such that at least a portion 410 of the catheter or tube contains an electrical connection 152 to the blood pump 150 .

[0064] As another illustrative example, a tube or catheter can be connected to an access delivery device (e.g., an access sheath) where a blood sample is drawn from another part of the body (e.g., an artery near the delivery site of an intravascular blood pump). In such an embodiment, catheter or tube 400 can be operably connected to patient 500 at insertion point 420 of intravascular blood pump 150.

[0065] refer to Figure 2E In some embodiments, the catheter or tube 400 can also be operably connected to the patient 500 at a location 430 different from the insertion point 420 of the intravascular blood pump 150, wherein the catheter or tube 400 is configured to transfer a blood sample from the patient to the first port 243. For example, the intravascular blood pump can be inserted through the jugular vein, and the catheter or tube 400 is operably connected to the access site at the femoral artery.

[0066] refer to Figure 2FIn some embodiments, the blood sample can be collected separately and manually transferred to the system (e.g., via port 243). In some embodiments, the blood sample can be collected using a syringe 600. In some embodiments, the blood sample can then be provided directly to the patient console 111 and / or the blood monitoring console 221, and / or can be injected into the tube 400 for delivery to the system 101.

[0067] Reference again Figure 1 In some embodiments, the system 100 can also include a second port 250 configured to allow blood to exit the housing. In some embodiments, the second port 250 can be connected to a waste stream 330. In some embodiments, the second port 250 can be operably coupled to a container 335 for disposing of biohazardous materials.

[0068] In some embodiments, blood monitoring sensor 210 may be configured to sense a blood parameter of a blood sample 300 received in first port 243 .

[0069] refer to Figure 3 In some embodiments, the blood monitoring sensor 212 may be disposed in or on the intravascular blood pump 150. In some embodiments, the patient console 114 and / or the blood monitoring console may not have the first port. The system may still include a blood monitoring module 204 within the patient console 114 and / or the blood monitoring console, but the blood monitoring sensor 212 may be remotely located (here, in or on the blood pump).

[0070] like Figure 3 As shown, in some embodiments, information from blood monitoring sensor 212 can be transmitted to a patient console and / or a blood monitoring console via catheter or tube 400 (e.g., via one or more wires). In some embodiments, catheter or tube 400 can be the same catheter or tube that is operably connected to intravascular blood pump 150.

[0071] refer to Figure 4 In some embodiments, some or all of the blood monitoring console and sensors may be operably coupled to the patient. In some embodiments, one or more patches 600 may be attached to an arm 530 or other suitable location of the patient 500. In some embodiments, the patch 600 may include a substrate 620 that may have a surface that adheres to the patient's skin. Each patch 600 may independently include a circuit 610 that may include some or all of the blood monitoring console and / or sensors (e.g., from each of the plurality of blood monitoring consoles and sensors). Figure 1200 and 210). For example, in some embodiments, patch 600 may include a blood monitoring sensor that senses a blood parameter and transmits the parameter to a patient console and / or a blood monitoring console.

[0072] In some embodiments, each patch may be operably coupled 630 to the patient console 114 and / or the blood monitoring console. This may be accomplished by wire or wirelessly.

[0073] Reference again Figure 1 In some embodiments, the system 100 may include one or more processors 160 , 260 . In some embodiments, the pump control module 140 and the blood monitoring module 200 may be operably coupled 145 to at least one of the one or more processors 160 , 260 .

[0074] In some embodiments, the system includes a single processor (e.g., processor 160). In some embodiments, the system includes multiple processors, including a first processor 160 and a second processor 260. In some embodiments, the pump control module 140 may include the first processor 160. In some embodiments, the blood monitoring module 200 may include the second processor 260.

[0075] In some embodiments, the system 100 may include a non-transitory computer-readable storage medium 180. In some embodiments, the computer-readable storage medium may contain instructions that, when executed by one or more processors, cause the system to first receive information about a blood sample from a sensor. Then, the system may determine a value of a blood parameter based on the information about the blood sample. Finally, the system may display the value of the blood parameter on a first display screen and / or a second display screen.

[0076] In some embodiments, the blood parameters sensed can be stored on the patient console and / or the blood monitoring console. As will be appreciated, in some embodiments, the system can also be operably connected to a cloud-based system (e.g., via one or more wires or wirelessly), which can transmit the sensing data from the system. As will be further appreciated, in some embodiments, information about a blood sample can be sent to a cloud-based system, where the information can be converted to blood parameters. Thereafter, the blood parameters can be sent back to the patient console and / or the blood monitoring console, where the blood parameters are displayed on one of the screens.

[0077] In some embodiments, the one or more processors are also configured with instructions that, when executed, cause the system to receive a blood sample. For example, if a box or vial containing a blood sample is inserted into the first slot, the system can be configured to cause the vial or box to be identified as having been inserted and / or detect whether it includes a blood sample. In some embodiments, the system can be configured to contact at least a portion of the blood sample with a blood monitoring sensor. In some embodiments, the processor can be configured to cause the blood sample to be retrieved by an intravascular blood pump. In some embodiments, the processor can be configured to cause the blood sample to be transported to a housing (a first housing or a second housing, depending on the configuration of the system) via a conduit or tube.

[0078] In some embodiments, the one or more processors may also be configured with instructions that, when executed, cause the system to adjust one or more valves to control the flow of a blood sample through the system. In some embodiments, this may include opening or closing a valve in or on the blood pump itself. In some embodiments, this may include opening while closing a valve to a vacuum source so that blood is pulled along the tube toward the housing.

[0079] The flowchart of the method embodiment is shown in Figure 5 The method 700 includes operating 710 a blood pump, such as an intravascular blood pump. The blood pump may be operated via a module at least partially disposed in a patient console. Figure 5 , which is shown as a step that occurs recursively. However, it should be understood that it may occur at any or all other times, and that the blood pump may continue to operate while the remainder of the method is performed. It should be understood that although the use of a blood pump is shown, it should be understood that the method may not include this step (e.g., if such monitoring is performed before or after the use of the blood pump).

[0080] Also like Figure 5 As shown, method 700 may include receiving 720 information about the blood sample from a blood monitoring sensor. It will be appreciated that this may include receiving an analog signal from the sensor or a digital signal containing sensor information. In some embodiments, the information may be received from a blood monitoring sensor in a blood monitoring console or patient console (e.g., via port 243 from a vial inserted through one or more tubes or catheters). In some embodiments, the information may be received from a blood monitoring sensor in or on a blood pump. In some embodiments, the information may be received from a blood monitoring sensor configured to be placed on a monitoring patch on the patient's body.

[0081] The method may include determining 730 a value of a blood parameter based on the received blood sample information. The blood parameter may be or may relate to blood coagulation. In some embodiments, the blood parameter may include prothrombin time (PT). In some embodiments, the blood parameter may include an international normalized ratio (INR).

[0082] The method may also include displaying 740 the value of the blood parameter on a display screen of the patient console and / or the blood monitoring console. In some embodiments, this may include displaying the numerical value of the blood parameter on the display screen. The method may also include displaying 600 a visual indication of the sensed blood parameter. For example, in some embodiments, Figure 6 As shown, the display can be configured to display a color mark (e.g., red 602, yellow 604, green 606) depending on whether the blood parameter falls within (or outside) a set threshold. In some embodiments, a threshold line can be displayed. As will be understood, based on the color mark shown, such visual marks can also serve as an alert to the physician. It will be understood that in some embodiments, the visual mark can include a slider or other suitable mark.

[0083] The method may also include receiving 750 a blood sample on one of a patient console and a blood monitoring console. Upon receiving, a blood monitoring sensor (which may be part of a blood monitoring module) may be utilized to detect or sense information about the blood sample. In some embodiments, receiving a blood sample may include receiving a blood sample in a first port disposed on a patient console or a blood monitoring console. In some embodiments, the sample may be in a box or a vial. In some embodiments, the sample may be provided via a catheter or a tube. In some embodiments, the first port may be configured to be operably coupled to a catheter or a tube. In some embodiments, the catheter may be configured to transfer a blood sample from a patient to the first port. In some embodiments, the method may include obtaining 751 a blood sample. In some embodiments, this may be accomplished using an intravascular blood pump. In some embodiments, this may be accomplished manually (e.g., using a needle / syringe to draw blood from a patient).

[0084] The method may also include predicting 770 at least one other parameter using the value of the blood parameter. In some embodiments, the value of a sensor coupled to the blood pump may also be used to predict at least one other parameter. In some embodiments, a trained machine learning algorithm may be used to predict at least one other parameter. In some embodiments, the trained machine learning algorithm may also use values ​​from a thromboelastogram to predict at least one other parameter. In some embodiments, the other parameters may include a prediction of heart failure made when the blood pump is at least partially located within the left ventricle. In some embodiments, the at least one other parameter may include a prediction of a bleeding condition.

[0085] The method may also include controlling providing an alert 760 to a clinician based on the value of a blood parameter or a parameter predicted using the value of a blood parameter. For example, if the value is outside a desired threshold, the clinician may receive an alert (e.g., provide more anticoagulant). In other embodiments, the alert may suggest that the clinician modify the operation of the blood pump. For example, if the blood parameter is an increase in the percentage of blood coagulation, it may be useful to adjust the flow characteristics of the blood through the blood pump by adjusting the speed of the pump to reduce the risk of thrombosis. It should be understood that in some embodiments, the method may include controlling the blood pump (e.g., by adjusting the speed of the pump) in response to the blood parameter.

[0086] The method may also include determining 780 an anticoagulation measure based on the predicted at least one other parameter. The method may also include displaying 781 the anticoagulation measure and / or automatically formulating 782 the anticoagulation measure. In some embodiments, the anticoagulation measure includes a dose of an anticoagulant. In some embodiments, the anticoagulation measure includes a dose of heparin or protamine. For example, the method may include determining an appropriate dose of heparin.

[0087] Similar to the blood parameters, in some embodiments, the method may include displaying the anticoagulation measure on a display. In some embodiments, this may include displaying a numerical value on a display. Figure 6 As shown, this can include displaying a visual marker 600 (e.g., a colored marker—red 602, yellow 604, green 606), depending on whether the anticoagulation measure falls within (or outside) a set threshold. It will be appreciated that, based on the markers shown, such visual markers can also serve as an alert to the physician. For example, in some embodiments, this can alert the clinician that, based on the sensed blood parameters (and the displayed anticoagulation measure), the patient may require more (or less) anticoagulant. It will be appreciated that, in some embodiments, the visual markers can include sliders or other suitable markers.

[0088] Those skilled in the art will recognize or be able to ascertain using no more than routine experimentation many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the appended claims.

Claims

1. A system comprising: a patient console having a first housing with a first display screen; a pump control module disposed at least partially within the first housing, the pump control module being configured to control an intravascular blood pump and to display information about the blood pump on the display screen; as well as A blood monitoring module is configured to derive a value of a blood parameter based on information about a blood sample received from a blood monitoring sensor, and to display the value of the blood parameter on a first display screen and / or a second display screen.

2. The system of claim 1 further comprising a processor.

3. The system according to claim 2, wherein: The pump control module and the blood monitoring module are operably coupled to the processor.

4. The system according to claim 2 or 3, wherein: The processor includes a plurality of processors including a first processor and a second processor, the pump control module further includes the first processor, and the blood monitoring module further includes the second processor.

5. The system according to any one of claims 1 to 4, wherein: The blood monitoring module is inside the first shell.

6. The system according to any one of claims 1 to 4, further comprising a blood monitoring console, wherein the blood monitoring console has a second housing, the second housing having the second display screen, wherein: The blood monitoring module is disposed in the second housing.

7. The system according to claim 6, wherein: The blood monitoring console is coupled to the patient console.

8. The system according to claim 7, wherein: The blood monitoring console is removably coupled to the first housing.

9. The system according to claim 7, wherein: The blood monitoring module is at least partially disposed in the first housing.

10. The system according to any one of claims 7 to 9, wherein: The processor is disposed only in the first housing.

11. The system of any one of claims 1 to 10, further comprising a first port configured to receive the blood sample.

12. The system according to claim 11, wherein: The blood monitoring sensor is configured to sense a blood parameter of the blood sample received in the first port.

13. The system according to claim 11, wherein: The first port is disposed in a blood monitoring console coupled to the patient console.

14. The system according to claim 11, wherein: The first port is disposed in the patient console.

15. The system according to claim 11, wherein: The first port is configured to removably receive a cartridge containing the blood sample.

16. The system according to claim 11, wherein: The first port is configured to be operably coupled to a catheter or tube.

17. The system of claim 16, wherein: The catheter or tube is also configured to contain an electrical connection to the blood pump.

18. The system of claim 16, wherein: The catheter is operably connected to a patient at a location different from an insertion point of the intravascular blood pump, and wherein the catheter is configured to transfer the blood sample from the patient to the first port.

19. The system of claim 18, wherein: The catheter is operably connected to the intravascular blood pump, wherein the catheter is configured to transfer the blood sample from the patient to a first port.

20. The system of any one of claims 16 to 19, further comprising a second port configured to allow blood to exit the housing.

21. The system of claim 20, wherein: The second port is connected to a waste stream.

22. A system according to any one of claims 1 to 21, wherein: The blood monitoring sensor is disposed on the intravascular blood pump.

23. A system according to any one of claims 1 to 22, wherein: The blood parameter includes or relates to blood coagulation.

24. A system according to any one of claims 1 to 23, wherein: The blood parameters include prothrombin time (PT), activated clotting time (ACT), clot proliferation rate, clot strength, clot dissociation rate, platelet mapping, functional fibrinogen and / or fibrin polymerization.

25. A system according to any one of claims 1 to 24, wherein: Values ​​associated with the blood parameters include the International Normalized Ratio (INR).

26. A system comprising: a pump control module configured to control an intravascular blood pump; as well as one or more processors in operable communication with the pump control module, the one or more processors being within a patient console and / or a blood monitoring console, and the one or more processors being configured with instructions that, when executed by the one or more processors, cause the system to: receiving information about the blood sample from the sensor; determining a value of a blood parameter based on the information about the blood sample; and The value of the blood parameter is displayed on the first display screen and / or the second display screen.

27. The system of claim 26, wherein: The one or more processors are also configured with instructions that, when executed, cause the system to receive the blood sample.

28. The system of claim 26 or 27, wherein: The processor includes a plurality of processors including a first processor and a second processor, the pump control module further includes the first processor, and the blood monitoring module further includes the second processor.

29. A system according to any one of claims 26 to 28, wherein: The pump control module is at least partially disposed in the first housing.

30. The system of claim 29, wherein: The blood monitoring module is at least partially disposed in the first housing.

31. The system of claim 30, wherein: The blood monitoring module is inside the first shell.

32. The system of claim 29, wherein: The blood monitoring module is disposed in a second housing having the second display screen.

33. The system of claim 32, wherein: The second housing is coupled to the first housing.

34. The system of claim 32, wherein: The second housing is removably coupled to the first housing.

35. A system according to any one of claims 26 to 34, wherein: The one or more processors are also configured to cause a blood sample to be delivered to the blood monitoring console.

36. The system of claim 35, wherein: The blood sample is retrieved by an intravascular blood pump.

37. The system of claim 35, wherein: The blood sample is delivered to the housing via a catheter.

38. A system according to any one of claims 26 to 37, wherein: The one or more processors are also configured with instructions that, when executed, cause the system to adjust one or more valves used to control the flow of the blood sample through the system.

39. A system according to any one of claims 26 to 38, wherein: The blood parameter includes or relates to blood coagulation.

40. A system according to any one of claims 26 to 39, wherein: The blood parameters include prothrombin time (PT), activated clotting time (ACT), clot proliferation rate, clot strength, clot dissociation rate, platelet mapping, functional fibrinogen and / or fibrin polymerization.

41. A system according to any one of claims 26 to 40, wherein: Values ​​associated with the blood parameters include the International Normalized Ratio (INR).

42. A method comprising: receiving information about a blood sample from a blood monitoring sensor; determining a value of a blood parameter based on the received blood sample information, wherein the blood parameter is blood coagulation or is related to blood coagulation; displaying the value of the blood parameter on a display screen of the patient console and / or the blood monitoring console; and The blood pump is operated via a pump control module that is at least partially disposed in the patient console.

43. The method of claim 42, further comprising controlling the blood pump based on the determined value of the blood parameter.

44. The method of any one of claims 42 to 43, further comprising using the value of the blood parameter to predict at least one other parameter.

45. The method of claim 44, wherein: The value of a sensor coupled to the blood pump is also used to predict the at least one other parameter.

46. ​​The method according to any one of claims 42 to 43, wherein: The trained machine learning algorithm is used to predict at least one other parameter.

47. The method of claim 46, wherein: The trained machine learning algorithm also uses values ​​from the thromboelastogram to predict the at least one other parameter.

48. The method of any one of claims 44 to 47, further comprising determining an anticoagulation measure based on the predicted at least one other parameter.

49. The method of claim 48, further comprising displaying the anticoagulation measure.

50. The method of claim 48, further comprising automatically formulating the anticoagulation measure.

51. The method according to any one of claims 48 to 50, wherein: The anticoagulation measures include doses of heparin or protamine.

52. The method according to any one of claims 44 to 51, wherein: The at least one other parameter comprises a prediction of heart failure.

53. The method of claim 52, wherein: The prediction of heart failure is a prediction of right heart failure.

54. The method of claim 52, wherein: The blood pump is positioned at least partially within the left ventricle.

55. The method according to any one of claims 44 to 54, wherein: The at least one other parameter comprises a prediction of a bleeding condition.

56. The method of any one of claims 42 to 55, further comprising receiving the blood sample at the patient console or the blood monitoring console.

57. The method of claim 56, wherein: Receiving the blood sample includes receiving the blood sample in a first port disposed on the patient console or the blood monitoring console.

58. The method of claim 57, wherein: The blood samples were in vials.

59. The method of claim 57, wherein: The first port is configured to be operably coupled to a catheter or tube.

60. The method of claim 59, wherein: The catheter is configured to transfer the blood sample from a patient to the first port.

61. The method of any one of claims 42 to 60, further comprising obtaining the blood sample via the intravascular blood pump.

62. The method according to any one of claims 42 to 61, wherein: The blood parameters include prothrombin time (PT), activated clotting time (ACT), clot proliferation rate, clot strength, clot dissociation rate, platelet mapping, functional fibrinogen and / or fibrin polymerization.

63. The method according to any one of claims 42 to 62, wherein: Values ​​associated with the blood parameters include the International Normalized Ratio (INR).

64. A method comprising: receiving a value of a blood parameter from a blood monitoring sensor of a monitoring patch configured to be placed on a patient's body; displaying the value of the blood parameter on a display screen of the patient console; as well as An intravascular blood pump is operated via a module at least partially disposed in the patient console.

65. The method of claim 64, further comprising controlling the blood pump based on the value of the blood parameter.

66. The method of claim 64 or 65, further comprising using the value of the blood parameter to predict at least one other parameter.

67. The method of claim 66, wherein: The value of a sensor coupled to the blood pump is also used to predict the at least one other parameter.

68. The method of claim 64 or 65, wherein: The trained machine learning algorithm is used to predict at least one other parameter.

69. The method of claim 68, wherein: The trained machine learning algorithm also uses values ​​from the thromboelastogram to predict the at least one other parameter.

70. The method of any one of claims 66 to 69, further comprising determining an anticoagulation measure based on the predicted at least one other parameter.

71. The method of claim 70, further comprising displaying the anticoagulation measure.

72. The method of claim 70, further comprising automatically formulating the anticoagulation measure.

73. The method according to any one of claims 70 to 72, wherein: The anticoagulation measures include doses of heparin or protamine.

74. The method of any one of claims 66 to 73, wherein: The at least one other parameter comprises a prediction of heart failure.

75. The method of claim 74, wherein: The prediction of heart failure is a prediction of right heart failure.

76. The method of claim 75, wherein: The blood pump is positioned at least partially within the left ventricle.

77. The method of any one of claims 66 to 76, wherein: The at least one other parameter comprises a prediction of a bleeding condition.

78. The method of any one of claims 66 to 77, wherein: The blood parameter includes or relates to blood coagulation.

79. The method of any one of claims 65 to 78, wherein: The blood parameters include prothrombin time (PT), activated clotting time (ACT), clot proliferation rate, clot strength, clot dissociation rate, platelet mapping, functional fibrinogen and / or fibrin polymerization.

80. The method of any one of claims 66 to 79, wherein: Values ​​associated with the blood parameters include the International Normalized Ratio (INR).